Investors have ridden tech stocks and the S&P 500 for years. But the time for large-caps might finally be coming to an end.

The high-profile CEO and artificial intelligence (AI) expert thinks software stocks have been unfairly sold off due to ...

This CNS drug developer with a diverse pipeline just saw a key insider trim their stake, according to recent filings.

Rick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most authoritative publications, including Good Morning America, Washington Post, ...

The burrito chain's recent comparable restaurant sales declines suggest its struggles could go beyond just a tough ...

American Express has been a good dividend growth stock to own over the years. It has generated strong returns and also ...

Feb. 5, 2026. This disposition represented 12.09% of Foulkes' holdings at the time of sale. No indirect participation or ...

This biopharma company advancing cardiac drug candidates disclosed a notable insider sale amid late-stage clinical ...

Alliance Laundry Holdings designs and supplies commercial laundry equipment and services to institutional and commercial ...

Summer Partners disclosed a new position in Globalstar following the satellite communications company’s sharp stock rally. Its network connects devices far beyond the reach of traditional cellular ...

Shares of Hims & Hers Health ( HIMS +40.79%) skyrocketed after the telemedicine platform came to an agreement with Novo ...

Micron has been a key beneficiary of the accelerating adoption of AI, as a key supplier to Nvidia. However, reports suggest that Micron's biggest competitors will be the sole suppliers of HBM4 for ...